Health
MediWelcome Soars 26% in Trading Debut
HONG KONG, Jan, 22, 2021 /PRNewswire/ -- Mediwelcome Healthcare Management & Technology Inc. ("MediWelcome") commenced trading of its shares on the Main Board of SEHK on19 Jan, 2021. The stock code of MediWelcome is 2159. Shares of MediWelcome were actively traded and opened atHK$4.00, up 33% aga...
2021-01-22 19:39
12290
Nanoform's Clinical Study Indicates Positive Interim Results
HELSINKI, Jan. 22, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful. Nanoform has received...
2021-01-22 15:43
1815
Elekta divests its stake in ViewRay
STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction. The shares in ViewRay were purchase...
2021-01-22 14:51
5350
GS1 HK and Zenecom join hands to help local merchants seize trillions O2O opportunities in Mainland medical, healthcare and beauty markets
HONG KONG, Jan. 22, 2021 /PRNewswire/ -- GS1 Hong Kong (GS1 HK) and Zenecom International Group Co. Ltd (Zenecom) formally signed a strategic cooperation agreement to launch "HK Trusted Market + WJH" initiative. Capitalising on the cross-border "Big Health" e-commerce platform WJH, the programme ...
2021-01-22 14:25
2742
Nippon Express (China) Inks MOU on Logistics Business Partnership with Jointown Pharmaceutical Group Logistics
TOKYO, Jan. 22, 2021 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NE China"), a subsidiary of Nippon Express Co., Ltd. of Tokyo, signed a memorandum of understanding (MOU) onDecember 18, 2020, over business partnership with Jointown Pharmaceutical Group Logistics Co., Ltd. (here...
2021-01-22 14:00
4006
Havas Health & You Evolves Network Positioning, Announces Chief Content Officer Hire Lars Bengston, and Launches Content Assembly
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- 2020 was a monumental year for all industries, and an especially formative time for health. The pandemic forced care providers, hospital systems and health brands to adapt and pivot at unprecedented speed and scale, with major industry players leaning into ...
2021-01-22 03:00
2097
Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- ELZONRIS is the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, inEurope - Approval is based on the results of the largest prospective clinical trial ever conducted in patients with treatment-naïve or previously-treated BPDCN FLORENCE, Italy, Ja...
2021-01-22 02:25
4515
AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site
BOULDER, Colo., Jan. 22, 2021 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the startup, strategic development and operational excellence in large-scale biologics production ...
2021-01-22 02:00
3770
Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance
STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering the implants in the U.S. market are also ongoing. "I am very pleased that the CE mark has been secured for B...
2021-01-22 01:59
2692
EyeQue Acclaimed by Frost & Sullivan for Its Wide Range of Consumer-friendly, Hand-held Ophthalmic Monitoring Solutions
SANTA CLARA, Calif., Jan. 21, 2021 /PRNewswire/ -- Based on its recent analysis of the global home-based ophthalmic monitoring solutions market, Frost & Sullivan recognizesEyeQue Corporation with the 2020 Global Growth Excellence Frost Radar Award. EyeQue's innovative yet affordable smartphone-po...
2021-01-21 22:00
2169
MGI Concurs With UK Court's Ruling to Invalidate Illumina's Patent
SAN JOSE, Calif., Jan. 21, 2021 /PRNewswire/ -- MGI, a subsidiary of BGI Group, announces today an official statement in response to the ruling of the Patents Court within the High Court of Justice forEngland & Wales on 20 January 2021 and calls for fair competition in the gene-sequencing market....
2021-01-21 21:24
2405
Envirotainer Opens First RAP e2 Station in Taipei
UPPLANDS VÄSBY , Sweden, Jan. 21, 2021 /PRNewswire/ -- Envirotainer, the global market leader and by far the largest provider of secure cold chain solutions for air transport of pharmaceuticals, today announced that they are expanding their network of RAP e2 stations by addingTaipei (TPE) to its ...
2021-01-21 16:14
2377
Shanghai Electric Strengthens Environmental, Social, and Corporate Governance for Dubai MBR Solar Park Project
SHANGHAI, Jan. 21, 2021 /PRNewswire/ -- Shanghai Electric Group ("Shanghai Electric" or "the Company") has strengthened its environmental, social, and corporate governance for the Phase 5 project forDubai's 900MW Mohammed bin Rashid Al Maktoum Solar Park (MBR Solar Park), winning praise from Shua...
2021-01-21 16:13
7783
LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Japan and Brazil; Italy Recommends Expansion of Microfluidic Antigen Testing
LONDON, Jan. 21, 2021 /PRNewswire/ -- LumiraDx, the next-generation point-of-care diagnostic testing company, announced today multinational approvals of its SARS-CoV-2 Antigen Test. With approvals inJapan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test is now available to patie...
2021-01-21 16:00
2306
CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021
SHANGHAI, Jan. 21, 2021 /PRNewswire/ -- The recently hosted CPhI & P-MEC China 2020 -- organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. -- attracted a remarkable 46,157 visits of professional pharma visitors, includ...
2021-01-21 16:00
2838
Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area
WALTHAM, Mass., Jan. 21, 2021 /PRNewswire/ -- Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site inEurope, announced at the virtual grand opening ceremony o...
2021-01-21 12:35
1638
Seegene to advance business in Latin America in the New Year
SEOUL, South Korea, Jan. 21, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) said Wednesday that it is expanding its business inLatin America in the new year with a strong focus on its multiplex assay product. Seegene said it received an approval f...
2021-01-21 07:56
2386
ERBA Mannheim Launches 2nd Generation SARS-CoV-2 RT-PCR Assay with room temperature storage
LONDON, Jan. 21, 2021 /PRNewswire/ -- In response to the ongoing COVID-19 pandemic, Erba today launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2. To overcome challenges in older COVID-19 molecular tests, Erba's Cambridge (UK)-based development team has carefully engineered a ...
2021-01-21 06:00
2616
Highlands Investments launches Africa's first contract cultivation offering - Canna-Tract™
Highlands Investments, a licensed cultivator of high-quality, low-cost medical grade cannabis, today launches Canna-Tract™ CAPE TOWN, South Africa, Jan. 21, 2021 /PRNewswire/ -- "Canna-Tract is Africa's first cannabis contract cultivation offering. Canna-Tract provides clients looking to grow co...
2021-01-21 00:03
2578
Merck Announces Update on the INTR@PID Clinical Program Including Lung 037 Study
DARMSTADT, Germany, Jan. 20, 2021 /PRNewswire/ -- Not intended for US-, Canada- or UK-based media Merck, a leading science and technology company, today announced an update on the Phase III INTR@PID Lung 037 study and the extensive INTR@PID clinical trial program for the potential first-in-class...
2021-01-20 23:35
2189
Week's Top Stories
Most Reposted
Amorepacific Showcases Innovative Technologies at CES 2026
[Picked up by 292 media titles]
2026-01-05 12:14
Novo Nordisk International Operations Commits to Veeva Vault CRM
[Picked up by 290 media titles]
2026-01-08 09:05Radisson Hotel Group Revives Bangkok Icon with Opening of Radisson Hotel Chateau de Bangkok
[Picked up by 283 media titles]
2026-01-06 10:45
Courtyard by Marriott Phuket, Patong Beach Resort: The Ultimate Family-Friendly Destination in 2026
[Picked up by 283 media titles]
2026-01-08 12:01
Panduit Announces Key Executive Appointments to Support Strategic Growth and Innovation
[Picked up by 282 media titles]
2026-01-07 10:00
Most Read
Supermicro Announces Support for Upcoming NVIDIA Vera Rubin NVL72, HGX Rubin NVL8 and Expanded Rack-Scale Manufacturing Capacity for Liquid-Cooled AI Solutions
2026-01-06 07:00
5119
YY Group Expands into Egypt's USD 20 Billion Hospitality Market
2026-01-05 21:30
4920
Samsung unveils hero products from its 2026 product line-up ahead of CES 2026
2026-01-03 07:22
4820